CA46437W1059 - XDNA (XNAS)
Kelly CRISPR & Gene Editing Technology ETF ETF
No Price
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -48,03 % |
Company Profile for Kelly CRISPR & Gene Editing Technology ETF ETF
The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.
Company Data to Kelly CRISPR & Gene Editing Technology ETF ETF
Name Kelly CRISPR & Gene Editing Technology ETF
Company Kelly CRISPR & Gene Editing Technology ETF
Symbol XDNA
Primary Exchange
NASDAQ
ISIN CA46437W1059
Asset Class ETF
Currency USD
Employees -
IPO Date 2022-01-13
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | XDNA |
More Shares
Investors who Kelly CRISPR & Gene Editing Technology ETF hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.